| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammasomes | 62 | 2024 | 324 | 10.370 |
Why?
|
| RNA, Long Noncoding | 19 | 2024 | 152 | 8.520 |
Why?
|
| Immunity, Innate | 64 | 2024 | 764 | 7.950 |
Why?
|
| Inflammation | 47 | 2025 | 1100 | 6.200 |
Why?
|
| Interferon Type I | 35 | 2024 | 169 | 5.860 |
Why?
|
| Membrane Proteins | 36 | 2025 | 842 | 5.760 |
Why?
|
| Signal Transduction | 107 | 2025 | 2885 | 5.610 |
Why?
|
| Gene Expression Regulation | 39 | 2020 | 1534 | 5.010 |
Why?
|
| Macrophages | 61 | 2025 | 1003 | 4.750 |
Why?
|
| Toll-Like Receptors | 45 | 2020 | 433 | 4.190 |
Why?
|
| Interleukin-1beta | 40 | 2021 | 263 | 4.060 |
Why?
|
| Nucleotidyltransferases | 17 | 2023 | 54 | 4.060 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 48 | 2023 | 256 | 3.850 |
Why?
|
| Interferons | 13 | 2024 | 64 | 3.800 |
Why?
|
| Animals | 222 | 2025 | 19562 | 3.780 |
Why?
|
| Mice | 175 | 2025 | 10237 | 3.550 |
Why?
|
| Carrier Proteins | 41 | 2015 | 709 | 3.380 |
Why?
|
| Immunity | 7 | 2021 | 96 | 2.930 |
Why?
|
| Pyroptosis | 8 | 2025 | 32 | 2.850 |
Why?
|
| Mice, Knockout | 93 | 2025 | 1984 | 2.530 |
Why?
|
| Caspase 1 | 25 | 2023 | 107 | 2.530 |
Why?
|
| Mice, Inbred C57BL | 95 | 2024 | 3183 | 2.410 |
Why?
|
| DNA | 20 | 2024 | 787 | 2.350 |
Why?
|
| Cytosol | 14 | 2019 | 167 | 2.260 |
Why?
|
| Autoimmunity | 9 | 2024 | 223 | 2.230 |
Why?
|
| Nuclear Proteins | 19 | 2021 | 759 | 2.200 |
Why?
|
| Virus Diseases | 9 | 2020 | 110 | 2.150 |
Why?
|
| Toll-Like Receptor 4 | 33 | 2024 | 347 | 2.130 |
Why?
|
| DNA-Binding Proteins | 31 | 2021 | 1128 | 2.090 |
Why?
|
| Membrane Glycoproteins | 26 | 2018 | 669 | 2.000 |
Why?
|
| Autoimmune Diseases | 6 | 2024 | 222 | 1.970 |
Why?
|
| RNA-Binding Proteins | 6 | 2025 | 384 | 1.970 |
Why?
|
| Colitis | 6 | 2024 | 75 | 1.920 |
Why?
|
| Caspase 8 | 11 | 2025 | 61 | 1.870 |
Why?
|
| Cytokines | 27 | 2023 | 906 | 1.840 |
Why?
|
| Interferon Regulatory Factor-3 | 31 | 2021 | 91 | 1.800 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 25 | 2015 | 83 | 1.800 |
Why?
|
| Humans | 166 | 2025 | 59224 | 1.790 |
Why?
|
| Receptors, Pattern Recognition | 7 | 2016 | 31 | 1.790 |
Why?
|
| Lipopolysaccharides | 30 | 2020 | 644 | 1.730 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 12 | 2020 | 322 | 1.720 |
Why?
|
| RNA, Viral | 11 | 2023 | 265 | 1.660 |
Why?
|
| Myeloid Differentiation Factor 88 | 39 | 2017 | 209 | 1.630 |
Why?
|
| DEAD-box RNA Helicases | 10 | 2017 | 76 | 1.580 |
Why?
|
| Apoptosis Regulatory Proteins | 13 | 2019 | 148 | 1.570 |
Why?
|
| Phosphate-Binding Proteins | 4 | 2020 | 17 | 1.460 |
Why?
|
| Neoplasms | 6 | 2024 | 1227 | 1.400 |
Why?
|
| Host-Pathogen Interactions | 14 | 2025 | 238 | 1.380 |
Why?
|
| Receptors, Cell Surface | 17 | 2007 | 438 | 1.350 |
Why?
|
| Transcription, Genetic | 10 | 2018 | 846 | 1.340 |
Why?
|
| Dendritic Cells | 25 | 2024 | 509 | 1.330 |
Why?
|
| NF-kappa B | 23 | 2023 | 461 | 1.250 |
Why?
|
| Interferon-beta | 18 | 2018 | 76 | 1.200 |
Why?
|
| Immune Evasion | 3 | 2024 | 53 | 1.190 |
Why?
|
| Cells, Cultured | 48 | 2020 | 2100 | 1.170 |
Why?
|
| Receptors, Immunologic | 15 | 2011 | 177 | 1.160 |
Why?
|
| Adaptive Immunity | 6 | 2021 | 89 | 1.120 |
Why?
|
| Transcription Factors | 14 | 2023 | 1456 | 1.110 |
Why?
|
| Viruses | 3 | 2020 | 79 | 1.110 |
Why?
|
| Lupus Erythematosus, Systemic | 6 | 2021 | 156 | 1.110 |
Why?
|
| Cytoskeletal Proteins | 12 | 2019 | 194 | 1.070 |
Why?
|
| Listeriosis | 5 | 2020 | 30 | 1.060 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 9 | 2025 | 78 | 1.050 |
Why?
|
| Apoptosis | 11 | 2023 | 1036 | 1.040 |
Why?
|
| Cell Line | 39 | 2021 | 2011 | 1.030 |
Why?
|
| Inflammatory Bowel Diseases | 4 | 2024 | 103 | 1.020 |
Why?
|
| Receptors, Interleukin-1 | 11 | 2013 | 64 | 1.020 |
Why?
|
| Virus Replication | 8 | 2025 | 302 | 1.020 |
Why?
|
| Interleukin-18 | 10 | 2021 | 74 | 1.020 |
Why?
|
| Mitochondria | 7 | 2024 | 333 | 1.010 |
Why?
|
| DNA Viruses | 4 | 2019 | 15 | 1.000 |
Why?
|
| Influenza A virus | 2 | 2025 | 117 | 0.990 |
Why?
|
| RNA Viruses | 3 | 2021 | 7 | 0.970 |
Why?
|
| Cell Death | 9 | 2023 | 267 | 0.940 |
Why?
|
| Intestinal Mucosa | 6 | 2024 | 221 | 0.930 |
Why?
|
| Endothelial Cells | 2 | 2024 | 175 | 0.930 |
Why?
|
| Tumor Escape | 1 | 2024 | 15 | 0.930 |
Why?
|
| Francisella tularensis | 3 | 2015 | 23 | 0.930 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2024 | 19 | 0.930 |
Why?
|
| Influenza, Human | 2 | 2025 | 193 | 0.910 |
Why?
|
| Th1 Cells | 4 | 2018 | 170 | 0.900 |
Why?
|
| Myeloid Cells | 2 | 2021 | 90 | 0.890 |
Why?
|
| Listeria monocytogenes | 6 | 2020 | 33 | 0.890 |
Why?
|
| Candidiasis | 3 | 2014 | 40 | 0.890 |
Why?
|
| Candida albicans | 3 | 2014 | 54 | 0.880 |
Why?
|
| GTP-Binding Proteins | 2 | 2015 | 80 | 0.870 |
Why?
|
| Ubiquitination | 4 | 2021 | 104 | 0.860 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2022 | 4 | 0.850 |
Why?
|
| T-Lymphocytes | 10 | 2024 | 959 | 0.850 |
Why?
|
| Familial Mediterranean Fever | 2 | 2020 | 9 | 0.850 |
Why?
|
| Tularemia | 2 | 2015 | 17 | 0.840 |
Why?
|
| Immune System | 2 | 2014 | 129 | 0.820 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2022 | 6 | 0.820 |
Why?
|
| Caspase 7 | 1 | 2022 | 18 | 0.820 |
Why?
|
| Lung Diseases, Interstitial | 2 | 2024 | 95 | 0.800 |
Why?
|
| Vascular Diseases | 1 | 2022 | 69 | 0.770 |
Why?
|
| RNA Virus Infections | 1 | 2021 | 2 | 0.770 |
Why?
|
| DNA, Bacterial | 6 | 2016 | 259 | 0.770 |
Why?
|
| Th17 Cells | 3 | 2018 | 52 | 0.760 |
Why?
|
| Adaptor Proteins, Signal Transducing | 23 | 2019 | 415 | 0.750 |
Why?
|
| Neutrophils | 3 | 2021 | 353 | 0.750 |
Why?
|
| Toll-Like Receptor 3 | 13 | 2017 | 67 | 0.740 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 158 | 0.730 |
Why?
|
| Malaria | 3 | 2024 | 101 | 0.730 |
Why?
|
| Proteins | 6 | 2020 | 742 | 0.720 |
Why?
|
| DNA, Protozoan | 4 | 2017 | 35 | 0.720 |
Why?
|
| Dimethyl Fumarate | 1 | 2020 | 8 | 0.720 |
Why?
|
| Dysbiosis | 1 | 2021 | 56 | 0.710 |
Why?
|
| Interferon-gamma | 10 | 2022 | 537 | 0.710 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2020 | 58 | 0.700 |
Why?
|
| Toll-Like Receptor 2 | 13 | 2019 | 220 | 0.690 |
Why?
|
| HEK293 Cells | 14 | 2021 | 568 | 0.690 |
Why?
|
| Phosphoproteins | 5 | 2014 | 216 | 0.690 |
Why?
|
| CARD Signaling Adaptor Proteins | 12 | 2024 | 60 | 0.680 |
Why?
|
| Cysteine | 1 | 2020 | 107 | 0.680 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2019 | 10 | 0.680 |
Why?
|
| Lymphocyte Activation | 14 | 2021 | 740 | 0.670 |
Why?
|
| Interferon Regulatory Factor-7 | 9 | 2021 | 33 | 0.660 |
Why?
|
| Cell Nucleus | 8 | 2020 | 602 | 0.660 |
Why?
|
| DNA, Neoplasm | 1 | 2019 | 51 | 0.660 |
Why?
|
| Caspases | 4 | 2020 | 164 | 0.660 |
Why?
|
| Xanthones | 4 | 2018 | 5 | 0.650 |
Why?
|
| Toll-Like Receptor 9 | 11 | 2018 | 197 | 0.650 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2018 | 16 | 0.640 |
Why?
|
| Multiprotein Complexes | 2 | 2010 | 148 | 0.630 |
Why?
|
| Gram-Negative Bacteria | 5 | 2017 | 54 | 0.630 |
Why?
|
| Immunity, Cellular | 2 | 2018 | 176 | 0.620 |
Why?
|
| Toll-Like Receptor 7 | 8 | 2018 | 97 | 0.610 |
Why?
|
| Hemeproteins | 3 | 2014 | 17 | 0.600 |
Why?
|
| Histones | 2 | 2020 | 463 | 0.600 |
Why?
|
| Peptide Fragments | 1 | 2019 | 353 | 0.600 |
Why?
|
| Herpesviridae Infections | 3 | 2015 | 28 | 0.590 |
Why?
|
| Autoantibodies | 8 | 2022 | 174 | 0.590 |
Why?
|
| Monocytes | 9 | 2024 | 351 | 0.590 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2015 | 238 | 0.580 |
Why?
|
| Multiple Sclerosis | 1 | 2020 | 208 | 0.580 |
Why?
|
| Interferon Regulatory Factors | 9 | 2024 | 39 | 0.580 |
Why?
|
| DNA, Viral | 6 | 2015 | 228 | 0.580 |
Why?
|
| Receptors, Interleukin | 10 | 2014 | 35 | 0.560 |
Why?
|
| Enterohemorrhagic Escherichia coli | 3 | 2014 | 13 | 0.560 |
Why?
|
| Immune System Diseases | 1 | 2017 | 17 | 0.550 |
Why?
|
| Bacterial Infections | 3 | 2014 | 139 | 0.550 |
Why?
|
| Adjuvants, Immunologic | 5 | 2018 | 228 | 0.550 |
Why?
|
| Malaria, Falciparum | 5 | 2022 | 114 | 0.550 |
Why?
|
| RNA Splicing | 4 | 2025 | 161 | 0.550 |
Why?
|
| Lectins, C-Type | 3 | 2025 | 82 | 0.550 |
Why?
|
| DNA Damage | 2 | 2018 | 275 | 0.540 |
Why?
|
| RNA | 6 | 2023 | 402 | 0.530 |
Why?
|
| Interferon Regulatory Factor-1 | 2 | 2015 | 5 | 0.530 |
Why?
|
| Citrobacter rodentium | 2 | 2014 | 5 | 0.530 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2016 | 13 | 0.530 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2016 | 69 | 0.530 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2024 | 140 | 0.520 |
Why?
|
| Protein Kinases | 5 | 2023 | 139 | 0.520 |
Why?
|
| Lung | 7 | 2024 | 822 | 0.510 |
Why?
|
| Nucleic Acids | 2 | 2016 | 50 | 0.510 |
Why?
|
| Allergy and Immunology | 1 | 2015 | 7 | 0.500 |
Why?
|
| Bacteriolysis | 1 | 2015 | 5 | 0.500 |
Why?
|
| CRISPR-Cas Systems | 5 | 2025 | 321 | 0.500 |
Why?
|
| Inflammation Mediators | 8 | 2015 | 169 | 0.490 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 2013 | 243 | 0.490 |
Why?
|
| I-kappa B Kinase | 8 | 2018 | 48 | 0.490 |
Why?
|
| Protein Binding | 12 | 2021 | 1544 | 0.490 |
Why?
|
| Interleukin-1alpha | 3 | 2015 | 25 | 0.480 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2015 | 88 | 0.480 |
Why?
|
| Disease Models, Animal | 19 | 2021 | 2057 | 0.480 |
Why?
|
| Fungal Polysaccharides | 1 | 2014 | 4 | 0.470 |
Why?
|
| Down-Regulation | 5 | 2020 | 306 | 0.470 |
Why?
|
| Macrophage-1 Antigen | 1 | 2014 | 31 | 0.470 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2016 | 236 | 0.470 |
Why?
|
| Molecular Biology | 1 | 2015 | 67 | 0.470 |
Why?
|
| Chemokine CCL8 | 1 | 2014 | 6 | 0.460 |
Why?
|
| beta-Glucans | 1 | 2014 | 47 | 0.460 |
Why?
|
| Plasmodium | 3 | 2024 | 29 | 0.440 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2014 | 87 | 0.440 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 5 | 2024 | 32 | 0.440 |
Why?
|
| Cyclic GMP | 5 | 2023 | 28 | 0.430 |
Why?
|
| Gain of Function Mutation | 2 | 2024 | 13 | 0.430 |
Why?
|
| Nucleotide Motifs | 1 | 2013 | 44 | 0.430 |
Why?
|
| Herpesvirus 1, Human | 5 | 2016 | 72 | 0.430 |
Why?
|
| RNA, Double-Stranded | 7 | 2015 | 107 | 0.430 |
Why?
|
| Killer Cells, Natural | 3 | 2013 | 214 | 0.430 |
Why?
|
| Ligands | 12 | 2024 | 421 | 0.420 |
Why?
|
| Drosophila Proteins | 4 | 2006 | 681 | 0.410 |
Why?
|
| Homeostasis | 3 | 2024 | 340 | 0.410 |
Why?
|
| Cytoplasm | 1 | 2013 | 272 | 0.400 |
Why?
|
| Hepatocytes | 5 | 2016 | 188 | 0.400 |
Why?
|
| Streptococcus agalactiae | 4 | 2016 | 80 | 0.400 |
Why?
|
| Virus Physiological Phenomena | 1 | 2011 | 7 | 0.380 |
Why?
|
| NLR Proteins | 2 | 2023 | 10 | 0.380 |
Why?
|
| Intestines | 2 | 2024 | 156 | 0.380 |
Why?
|
| Plasmodium falciparum | 4 | 2022 | 131 | 0.380 |
Why?
|
| Mice, Mutant Strains | 8 | 2021 | 304 | 0.370 |
Why?
|
| Gene Knockdown Techniques | 4 | 2020 | 193 | 0.370 |
Why?
|
| RNA, Messenger | 7 | 2020 | 1467 | 0.370 |
Why?
|
| Endoplasmic Reticulum Stress | 3 | 2016 | 38 | 0.370 |
Why?
|
| Herpesviridae | 1 | 2011 | 14 | 0.370 |
Why?
|
| Endosomes | 5 | 2016 | 169 | 0.370 |
Why?
|
| MicroRNAs | 4 | 2020 | 617 | 0.360 |
Why?
|
| Membrane Transport Proteins | 7 | 2016 | 119 | 0.360 |
Why?
|
| Antigens, Differentiation | 11 | 2005 | 140 | 0.360 |
Why?
|
| Catenins | 1 | 2010 | 9 | 0.350 |
Why?
|
| Genetic Vectors | 4 | 2021 | 797 | 0.350 |
Why?
|
| Nod Signaling Adaptor Proteins | 1 | 2010 | 1 | 0.350 |
Why?
|
| DNA Virus Infections | 1 | 2010 | 9 | 0.350 |
Why?
|
| Immunologic Surveillance | 3 | 2020 | 13 | 0.350 |
Why?
|
| Lymphocytes | 3 | 2024 | 193 | 0.350 |
Why?
|
| Interleukin-1 | 6 | 2023 | 154 | 0.350 |
Why?
|
| Viral Interference | 1 | 2009 | 2 | 0.350 |
Why?
|
| Metapneumovirus | 1 | 2009 | 6 | 0.350 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 3 | 2020 | 7 | 0.340 |
Why?
|
| Lymphocyte Antigen 96 | 2 | 2007 | 53 | 0.340 |
Why?
|
| Rift Valley Fever | 3 | 2013 | 4 | 0.340 |
Why?
|
| Rift Valley fever virus | 3 | 2013 | 4 | 0.340 |
Why?
|
| Integrin beta3 | 1 | 2009 | 9 | 0.330 |
Why?
|
| Macrophage Activation | 3 | 2020 | 119 | 0.330 |
Why?
|
| Autophagy | 4 | 2013 | 205 | 0.330 |
Why?
|
| Mutation | 9 | 2021 | 2424 | 0.330 |
Why?
|
| Viral Load | 3 | 2024 | 228 | 0.320 |
Why?
|
| Macrophages, Peritoneal | 7 | 2024 | 73 | 0.320 |
Why?
|
| RNA Helicases | 3 | 2006 | 88 | 0.320 |
Why?
|
| Adenoviridae | 1 | 2009 | 119 | 0.320 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2023 | 54 | 0.320 |
Why?
|
| Myelin Proteins | 5 | 2010 | 30 | 0.320 |
Why?
|
| Proteolipids | 5 | 2010 | 24 | 0.320 |
Why?
|
| Pyrin | 2 | 2020 | 7 | 0.320 |
Why?
|
| RNA Stability | 2 | 2022 | 93 | 0.310 |
Why?
|
| Cell Differentiation | 8 | 2024 | 1290 | 0.310 |
Why?
|
| RNA Interference | 7 | 2016 | 588 | 0.310 |
Why?
|
| Melanoma, Experimental | 2 | 2021 | 42 | 0.300 |
Why?
|
| Gene Deletion | 4 | 2018 | 298 | 0.300 |
Why?
|
| Enzyme Activation | 8 | 2020 | 351 | 0.300 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2024 | 580 | 0.290 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 11 | 2020 | 453 | 0.290 |
Why?
|
| Gene Expression | 7 | 2021 | 807 | 0.290 |
Why?
|
| Cyclooxygenase 2 | 4 | 2018 | 77 | 0.290 |
Why?
|
| Tumor Microenvironment | 3 | 2024 | 141 | 0.290 |
Why?
|
| Phosphorylation | 14 | 2020 | 861 | 0.290 |
Why?
|
| Interferon-alpha | 6 | 2014 | 99 | 0.290 |
Why?
|
| Nucleotides, Cyclic | 3 | 2023 | 13 | 0.280 |
Why?
|
| Plague | 3 | 2018 | 23 | 0.280 |
Why?
|
| Protein Transport | 6 | 2020 | 393 | 0.280 |
Why?
|
| Female | 29 | 2024 | 30789 | 0.280 |
Why?
|
| Self Tolerance | 1 | 2007 | 18 | 0.280 |
Why?
|
| Lipid A | 1 | 2007 | 70 | 0.280 |
Why?
|
| Chromatin | 3 | 2022 | 592 | 0.280 |
Why?
|
| Cell Line, Tumor | 6 | 2024 | 1366 | 0.270 |
Why?
|
| Interferon-Stimulated Gene Factor 3 | 1 | 2006 | 1 | 0.270 |
Why?
|
| Membrane Lipids | 1 | 2006 | 26 | 0.270 |
Why?
|
| MAP Kinase Kinase Kinases | 3 | 2018 | 74 | 0.270 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2006 | 16 | 0.270 |
Why?
|
| Bacterial Proteins | 7 | 2018 | 743 | 0.270 |
Why?
|
| Cell Membrane | 5 | 2022 | 489 | 0.270 |
Why?
|
| Mucous Membrane | 2 | 2018 | 19 | 0.270 |
Why?
|
| Trans-Activators | 2 | 2021 | 295 | 0.260 |
Why?
|
| Biomarkers | 3 | 2021 | 1204 | 0.260 |
Why?
|
| Chemokine CCL5 | 5 | 2014 | 33 | 0.260 |
Why?
|
| Fas Ligand Protein | 2 | 2018 | 39 | 0.260 |
Why?
|
| Immune Tolerance | 2 | 2024 | 169 | 0.260 |
Why?
|
| Promoter Regions, Genetic | 4 | 2021 | 656 | 0.260 |
Why?
|
| Arthritis, Experimental | 2 | 2016 | 29 | 0.250 |
Why?
|
| Receptor, Interferon alpha-beta | 5 | 2017 | 45 | 0.250 |
Why?
|
| A549 Cells | 2 | 2025 | 36 | 0.250 |
Why?
|
| Phenotype | 4 | 2024 | 1154 | 0.250 |
Why?
|
| Uric Acid | 2 | 2015 | 49 | 0.240 |
Why?
|
| Caspases, Initiator | 3 | 2013 | 4 | 0.240 |
Why?
|
| Adenosine Deaminase | 1 | 2025 | 16 | 0.240 |
Why?
|
| Male | 20 | 2024 | 27470 | 0.240 |
Why?
|
| Dinucleoside Phosphates | 2 | 2016 | 38 | 0.240 |
Why?
|
| Antigens, Surface | 3 | 2004 | 191 | 0.240 |
Why?
|
| Adenosine Triphosphate | 3 | 2015 | 287 | 0.240 |
Why?
|
| MAP Kinase Signaling System | 3 | 2013 | 201 | 0.240 |
Why?
|
| DNA, Mitochondrial | 3 | 2024 | 75 | 0.240 |
Why?
|
| Poly I-C | 3 | 2021 | 74 | 0.230 |
Why?
|
| Vaccines, DNA | 2 | 2015 | 99 | 0.230 |
Why?
|
| Pathogen-Associated Molecular Pattern Molecules | 2 | 2022 | 4 | 0.230 |
Why?
|
| Lysosomes | 6 | 2014 | 162 | 0.230 |
Why?
|
| Yersinia pestis | 3 | 2014 | 33 | 0.230 |
Why?
|
| Immunotherapy | 2 | 2024 | 225 | 0.230 |
Why?
|
| Succinates | 1 | 2024 | 8 | 0.230 |
Why?
|
| Repressor Proteins | 1 | 2006 | 336 | 0.230 |
Why?
|
| DEAD Box Protein 58 | 5 | 2013 | 17 | 0.230 |
Why?
|
| RNA, Untranslated | 2 | 2015 | 101 | 0.230 |
Why?
|
| Toxoplasmosis | 1 | 2024 | 18 | 0.230 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 34 | 0.220 |
Why?
|
| Protons | 1 | 2023 | 60 | 0.220 |
Why?
|
| STAT3 Transcription Factor | 3 | 2020 | 68 | 0.220 |
Why?
|
| Flow Cytometry | 10 | 2016 | 667 | 0.220 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2023 | 11 | 0.220 |
Why?
|
| Sendai virus | 3 | 2016 | 13 | 0.220 |
Why?
|
| Phagosomes | 3 | 2014 | 44 | 0.220 |
Why?
|
| Epithelial Cells | 2 | 2024 | 374 | 0.220 |
Why?
|
| RNA, Small Interfering | 5 | 2023 | 850 | 0.220 |
Why?
|
| Mycobacterium tuberculosis | 3 | 2013 | 383 | 0.220 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2024 | 104 | 0.220 |
Why?
|
| Gene Expression Profiling | 7 | 2017 | 696 | 0.220 |
Why?
|
| Mice, Transgenic | 8 | 2021 | 1219 | 0.210 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2024 | 132 | 0.210 |
Why?
|
| TNF Receptor-Associated Factor 6 | 4 | 2020 | 22 | 0.210 |
Why?
|
| Spleen | 5 | 2020 | 485 | 0.210 |
Why?
|
| Liver Diseases, Alcoholic | 2 | 2015 | 84 | 0.210 |
Why?
|
| Transcriptional Activation | 3 | 2013 | 188 | 0.210 |
Why?
|
| Osteoclasts | 1 | 2023 | 50 | 0.210 |
Why?
|
| Cell Movement | 2 | 2022 | 421 | 0.210 |
Why?
|
| Colitis, Ulcerative | 1 | 2024 | 83 | 0.210 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2022 | 1 | 0.210 |
Why?
|
| Keratinocytes | 1 | 2023 | 63 | 0.210 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2022 | 5 | 0.210 |
Why?
|
| Perforin | 1 | 2022 | 29 | 0.210 |
Why?
|
| STAT1 Transcription Factor | 2 | 2020 | 35 | 0.210 |
Why?
|
| B-Lymphocytes | 6 | 2018 | 550 | 0.200 |
Why?
|
| Molecular Sequence Data | 10 | 2014 | 1975 | 0.200 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2022 | 33 | 0.200 |
Why?
|
| Single-Domain Antibodies | 1 | 2022 | 16 | 0.200 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2020 | 255 | 0.200 |
Why?
|
| Lymphoid Tissue | 1 | 2022 | 55 | 0.200 |
Why?
|
| Calcium-Binding Proteins | 2 | 2013 | 84 | 0.200 |
Why?
|
| Nod2 Signaling Adaptor Protein | 2 | 2014 | 26 | 0.200 |
Why?
|
| Lymphocyte Depletion | 1 | 2022 | 95 | 0.200 |
Why?
|
| Microscopy, Confocal | 8 | 2015 | 219 | 0.200 |
Why?
|
| Radiation Tolerance | 1 | 2022 | 47 | 0.200 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 5 | 2009 | 125 | 0.200 |
Why?
|
| Protein Structure, Tertiary | 9 | 2014 | 663 | 0.200 |
Why?
|
| Cell Proliferation | 3 | 2022 | 940 | 0.200 |
Why?
|
| Armadillo Domain Proteins | 3 | 2019 | 20 | 0.200 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 93 | 0.200 |
Why?
|
| Hepatitis C, Chronic | 1 | 2022 | 88 | 0.190 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2021 | 646 | 0.190 |
Why?
|
| Liver | 3 | 2015 | 783 | 0.190 |
Why?
|
| Pancreatic Neoplasms | 1 | 2024 | 315 | 0.190 |
Why?
|
| Immunoblotting | 9 | 2014 | 190 | 0.190 |
Why?
|
| Cancer Vaccines | 1 | 2021 | 48 | 0.190 |
Why?
|
| Lymphocytic choriomeningitis virus | 2 | 2012 | 83 | 0.190 |
Why?
|
| THP-1 Cells | 1 | 2020 | 17 | 0.180 |
Why?
|
| Biological Phenomena | 1 | 2020 | 4 | 0.180 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 2 | 2014 | 8 | 0.180 |
Why?
|
| Endodeoxyribonucleases | 3 | 2016 | 40 | 0.180 |
Why?
|
| Streptococcus pneumoniae | 2 | 2011 | 59 | 0.180 |
Why?
|
| Histone Deacetylase 6 | 1 | 2020 | 7 | 0.180 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2020 | 71 | 0.180 |
Why?
|
| Immunophenotyping | 1 | 2021 | 191 | 0.180 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2014 | 208 | 0.180 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2021 | 179 | 0.180 |
Why?
|
| Gene Editing | 1 | 2025 | 285 | 0.180 |
Why?
|
| Erythrocytes | 4 | 2017 | 153 | 0.180 |
Why?
|
| Feedback | 1 | 2020 | 87 | 0.180 |
Why?
|
| Reactive Oxygen Species | 6 | 2023 | 201 | 0.180 |
Why?
|
| Citric Acid Cycle | 1 | 2020 | 25 | 0.180 |
Why?
|
| Arthritis, Gouty | 1 | 2020 | 1 | 0.180 |
Why?
|
| Provitamins | 1 | 2020 | 2 | 0.180 |
Why?
|
| Malaria, Cerebral | 1 | 2020 | 21 | 0.180 |
Why?
|
| Atherosclerosis | 2 | 2013 | 147 | 0.170 |
Why?
|
| RNA Precursors | 1 | 2020 | 74 | 0.170 |
Why?
|
| Organelles | 1 | 2020 | 16 | 0.170 |
Why?
|
| Interleukins | 1 | 2020 | 77 | 0.170 |
Why?
|
| Body Mass Index | 1 | 2024 | 891 | 0.170 |
Why?
|
| Amino Acid Sequence | 8 | 2014 | 1580 | 0.170 |
Why?
|
| beta Carotene | 1 | 2020 | 67 | 0.170 |
Why?
|
| Genetic Therapy | 2 | 2021 | 706 | 0.170 |
Why?
|
| Antineoplastic Agents | 4 | 2013 | 642 | 0.170 |
Why?
|
| Telomerase | 1 | 2019 | 30 | 0.160 |
Why?
|
| Cluster Analysis | 3 | 2015 | 250 | 0.160 |
Why?
|
| Vaccinia virus | 3 | 2011 | 71 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2018 | 15 | 0.160 |
Why?
|
| Protein Multimerization | 3 | 2016 | 163 | 0.160 |
Why?
|
| Myocardial Infarction | 2 | 2017 | 855 | 0.160 |
Why?
|
| Crystallography, X-Ray | 3 | 2012 | 419 | 0.160 |
Why?
|
| Melanoma | 2 | 2021 | 334 | 0.160 |
Why?
|
| Francisella | 1 | 2018 | 3 | 0.160 |
Why?
|
| Plasmodium chabaudi | 2 | 2020 | 23 | 0.160 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2018 | 30 | 0.160 |
Why?
|
| Mammals | 3 | 2022 | 203 | 0.160 |
Why?
|
| Oligonucleotides | 3 | 2023 | 206 | 0.160 |
Why?
|
| NADPH Oxidases | 3 | 2013 | 64 | 0.160 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2018 | 24 | 0.150 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2023 | 474 | 0.150 |
Why?
|
| Nanoparticles | 1 | 2024 | 496 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 7 | 2018 | 880 | 0.150 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 2018 | 13 | 0.150 |
Why?
|
| Cholesterol | 2 | 2010 | 255 | 0.150 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1058 | 0.150 |
Why?
|
| Embryonic Stem Cells | 1 | 2019 | 150 | 0.150 |
Why?
|
| Paracoccidioidomycosis | 1 | 2018 | 25 | 0.150 |
Why?
|
| Phagocytosis | 3 | 2014 | 252 | 0.150 |
Why?
|
| Peritonitis | 2 | 2016 | 33 | 0.150 |
Why?
|
| Paracoccidioides | 1 | 2018 | 37 | 0.150 |
Why?
|
| Sjogren's Syndrome | 1 | 2018 | 26 | 0.150 |
Why?
|
| Transfection | 8 | 2016 | 671 | 0.150 |
Why?
|
| Tuberculosis | 2 | 2012 | 261 | 0.150 |
Why?
|
| Aminoquinolines | 2 | 2015 | 15 | 0.150 |
Why?
|
| Fibroblasts | 4 | 2014 | 366 | 0.150 |
Why?
|
| Myelin and Lymphocyte-Associated Proteolipid Proteins | 5 | 2010 | 12 | 0.150 |
Why?
|
| Geographic Atrophy | 1 | 2017 | 20 | 0.150 |
Why?
|
| Models, Genetic | 1 | 2018 | 253 | 0.150 |
Why?
|
| Bacterial Secretion Systems | 2 | 2016 | 10 | 0.140 |
Why?
|
| Gram-Positive Bacteria | 2 | 2012 | 36 | 0.140 |
Why?
|
| RNA Polymerase II | 1 | 2017 | 70 | 0.140 |
Why?
|
| Real-Time Polymerase Chain Reaction | 5 | 2018 | 191 | 0.140 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2016 | 5 | 0.140 |
Why?
|
| 5' Untranslated Regions | 1 | 2017 | 23 | 0.140 |
Why?
|
| Neisseria gonorrhoeae | 2 | 2017 | 258 | 0.140 |
Why?
|
| Antiviral Agents | 4 | 2023 | 314 | 0.140 |
Why?
|
| Pyrophosphatases | 1 | 2016 | 9 | 0.140 |
Why?
|
| Child | 4 | 2022 | 4297 | 0.140 |
Why?
|
| Genes, Reporter | 5 | 2016 | 243 | 0.140 |
Why?
|
| Respirovirus Infections | 1 | 2016 | 6 | 0.140 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2016 | 7 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2017 | 82 | 0.130 |
Why?
|
| Chromatids | 1 | 2016 | 13 | 0.130 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2016 | 41 | 0.130 |
Why?
|
| Radiation Injuries | 1 | 2016 | 55 | 0.130 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2013 | 23 | 0.130 |
Why?
|
| Up-Regulation | 3 | 2013 | 362 | 0.130 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 47 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2015 | 522 | 0.130 |
Why?
|
| Microglia | 2 | 2016 | 227 | 0.130 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2016 | 77 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2014 | 158 | 0.130 |
Why?
|
| Protein Biosynthesis | 3 | 2014 | 291 | 0.130 |
Why?
|
| Transcriptome | 2 | 2016 | 322 | 0.130 |
Why?
|
| Cellular Microenvironment | 1 | 2015 | 20 | 0.130 |
Why?
|
| Interleukin-6 | 5 | 2022 | 309 | 0.130 |
Why?
|
| Caspase 2 | 1 | 2015 | 7 | 0.130 |
Why?
|
| Endotoxins | 2 | 2007 | 79 | 0.130 |
Why?
|
| Stromal Cells | 1 | 2016 | 65 | 0.130 |
Why?
|
| Czechoslovakia | 1 | 2015 | 1 | 0.130 |
Why?
|
| Probenecid | 1 | 2015 | 6 | 0.130 |
Why?
|
| Salmonella Infections | 2 | 2013 | 38 | 0.130 |
Why?
|
| Allopurinol | 1 | 2015 | 17 | 0.130 |
Why?
|
| Arthritis | 1 | 2015 | 49 | 0.120 |
Why?
|
| Models, Immunological | 2 | 2013 | 79 | 0.120 |
Why?
|
| RNA, Antisense | 1 | 2015 | 48 | 0.120 |
Why?
|
| Psoriasis | 1 | 2015 | 51 | 0.120 |
Why?
|
| Gammaherpesvirinae | 1 | 2015 | 4 | 0.120 |
Why?
|
| Chitosan | 1 | 2016 | 82 | 0.120 |
Why?
|
| GTPase-Activating Proteins | 2 | 2005 | 63 | 0.120 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2015 | 33 | 0.120 |
Why?
|
| Virus Latency | 1 | 2015 | 28 | 0.120 |
Why?
|
| Viral Proteins | 3 | 2010 | 260 | 0.120 |
Why?
|
| Alzheimer Disease | 2 | 2013 | 549 | 0.120 |
Why?
|
| Liver Cirrhosis | 1 | 2016 | 159 | 0.120 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2014 | 10 | 0.120 |
Why?
|
| Antibody Formation | 1 | 2014 | 111 | 0.120 |
Why?
|
| Salmonella typhimurium | 3 | 2013 | 80 | 0.120 |
Why?
|
| Genetic Loci | 2 | 2015 | 106 | 0.120 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2014 | 8 | 0.120 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 257 | 0.120 |
Why?
|
| History, 21st Century | 1 | 2015 | 161 | 0.120 |
Why?
|
| Cardiovirus Infections | 1 | 2014 | 13 | 0.120 |
Why?
|
| Peritoneum | 1 | 2014 | 25 | 0.120 |
Why?
|
| Encephalomyocarditis virus | 1 | 2014 | 14 | 0.120 |
Why?
|
| Dependovirus | 1 | 2021 | 655 | 0.120 |
Why?
|
| Antigen-Presenting Cells | 2 | 2014 | 176 | 0.120 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2014 | 22 | 0.120 |
Why?
|
| Potassium | 4 | 2018 | 109 | 0.120 |
Why?
|
| Bone Marrow Cells | 5 | 2014 | 228 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2015 | 226 | 0.110 |
Why?
|
| Pneumococcal Infections | 2 | 2011 | 35 | 0.110 |
Why?
|
| Polyadenylation | 1 | 2014 | 44 | 0.110 |
Why?
|
| RNA, Bacterial | 1 | 2014 | 70 | 0.110 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2013 | 10 | 0.110 |
Why?
|
| Thionucleotides | 1 | 2013 | 38 | 0.110 |
Why?
|
| Genomic Imprinting | 1 | 2013 | 49 | 0.110 |
Why?
|
| Hemolysin Proteins | 1 | 2014 | 45 | 0.110 |
Why?
|
| Immunoglobulin E | 1 | 2014 | 85 | 0.110 |
Why?
|
| Plasmodium vivax | 1 | 2014 | 31 | 0.110 |
Why?
|
| Malaria, Vivax | 1 | 2014 | 33 | 0.110 |
Why?
|
| Gadolinium | 1 | 2014 | 101 | 0.110 |
Why?
|
| CD36 Antigens | 1 | 2013 | 26 | 0.110 |
Why?
|
| Alternative Splicing | 1 | 2014 | 120 | 0.110 |
Why?
|
| Interleukin-17 | 1 | 2013 | 80 | 0.110 |
Why?
|
| Introns | 1 | 2013 | 106 | 0.110 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2014 | 79 | 0.110 |
Why?
|
| Viral Nonstructural Proteins | 2 | 2022 | 92 | 0.110 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2013 | 27 | 0.110 |
Why?
|
| DNA, Single-Stranded | 1 | 2014 | 100 | 0.110 |
Why?
|
| Exodeoxyribonucleases | 1 | 2013 | 28 | 0.110 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2013 | 6 | 0.110 |
Why?
|
| Arthritis, Infectious | 1 | 2013 | 18 | 0.110 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2013 | 72 | 0.100 |
Why?
|
| Acne Vulgaris | 1 | 2013 | 24 | 0.100 |
Why?
|
| Microbiota | 1 | 2014 | 106 | 0.100 |
Why?
|
| Serine O-Acetyltransferase | 1 | 2012 | 3 | 0.100 |
Why?
|
| Prions | 1 | 2012 | 24 | 0.100 |
Why?
|
| fas Receptor | 1 | 2012 | 54 | 0.100 |
Why?
|
| DNA, B-Form | 1 | 2012 | 2 | 0.100 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2012 | 51 | 0.100 |
Why?
|
| Cell Fusion | 1 | 2012 | 45 | 0.100 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2009 | 46 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2012 | 606 | 0.100 |
Why?
|
| Epithelium, Corneal | 1 | 2012 | 4 | 0.100 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 211 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 127 | 0.100 |
Why?
|
| Yersinia | 2 | 2025 | 7 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 2012 | 144 | 0.100 |
Why?
|
| Membrane Fusion | 1 | 2012 | 74 | 0.100 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2012 | 60 | 0.100 |
Why?
|
| Myxoma virus | 1 | 2011 | 1 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 157 | 0.100 |
Why?
|
| Immunoglobulin G | 3 | 2022 | 450 | 0.100 |
Why?
|
| AT Rich Sequence | 1 | 2011 | 5 | 0.100 |
Why?
|
| Contrast Media | 1 | 2014 | 408 | 0.100 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2011 | 10 | 0.100 |
Why?
|
| Serum Amyloid A Protein | 1 | 2011 | 8 | 0.100 |
Why?
|
| Heart Ventricles | 1 | 2013 | 250 | 0.090 |
Why?
|
| Allergens | 1 | 2011 | 43 | 0.090 |
Why?
|
| Cell Survival | 3 | 2019 | 552 | 0.090 |
Why?
|
| Receptors, IgG | 1 | 2011 | 36 | 0.090 |
Why?
|
| Respiratory System | 1 | 2011 | 41 | 0.090 |
Why?
|
| Molecular Docking Simulation | 2 | 2022 | 79 | 0.090 |
Why?
|
| Streptolysins | 1 | 2010 | 8 | 0.090 |
Why?
|
| Yersinia Infections | 2 | 2025 | 9 | 0.090 |
Why?
|
| Vesicular Stomatitis | 1 | 2010 | 1 | 0.090 |
Why?
|
| Brain | 2 | 2020 | 1487 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2011 | 677 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2010 | 82 | 0.090 |
Why?
|
| CpG Islands | 3 | 2010 | 212 | 0.090 |
Why?
|
| Immediate-Early Proteins | 1 | 2010 | 44 | 0.090 |
Why?
|
| Dimerization | 4 | 2019 | 145 | 0.090 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2010 | 21 | 0.090 |
Why?
|
| Bacteria | 1 | 2013 | 275 | 0.090 |
Why?
|
| Paramyxoviridae Infections | 1 | 2009 | 7 | 0.090 |
Why?
|
| Acute Lung Injury | 1 | 2010 | 39 | 0.090 |
Why?
|
| Gene Regulatory Networks | 2 | 2024 | 139 | 0.090 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2009 | 8 | 0.090 |
Why?
|
| Transcription Factor CHOP | 1 | 2009 | 6 | 0.090 |
Why?
|
| Immunologic Memory | 1 | 2012 | 276 | 0.090 |
Why?
|
| Vero Cells | 1 | 2009 | 74 | 0.090 |
Why?
|
| Chemokine CXCL10 | 2 | 2025 | 60 | 0.080 |
Why?
|
| Phylogeny | 1 | 2010 | 331 | 0.080 |
Why?
|
| Polyphosphates | 1 | 2009 | 12 | 0.080 |
Why?
|
| Receptors, Cytokine | 1 | 2009 | 14 | 0.080 |
Why?
|
| Second Messenger Systems | 1 | 2009 | 26 | 0.080 |
Why?
|
| Chlamydia Infections | 1 | 2010 | 77 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2010 | 113 | 0.080 |
Why?
|
| Asthma | 1 | 2013 | 417 | 0.080 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2009 | 15 | 0.080 |
Why?
|
| Poly dA-dT | 1 | 2009 | 7 | 0.080 |
Why?
|
| Species Specificity | 1 | 2009 | 336 | 0.080 |
Why?
|
| Arginase | 1 | 2008 | 6 | 0.080 |
Why?
|
| Unfolded Protein Response | 1 | 2009 | 53 | 0.080 |
Why?
|
| Cathepsins | 1 | 2009 | 32 | 0.080 |
Why?
|
| Polyubiquitin | 1 | 2008 | 8 | 0.080 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 3 | 2014 | 15 | 0.080 |
Why?
|
| Isoenzymes | 2 | 2006 | 134 | 0.080 |
Why?
|
| Mice, 129 Strain | 3 | 2014 | 40 | 0.080 |
Why?
|
| Interleukin-4 | 2 | 2014 | 137 | 0.080 |
Why?
|
| DNA Primers | 4 | 2014 | 291 | 0.080 |
Why?
|
| Chagas Disease | 1 | 2008 | 34 | 0.080 |
Why?
|
| Silicosis | 1 | 2008 | 4 | 0.080 |
Why?
|
| Interleukin-12 | 2 | 2024 | 124 | 0.080 |
Why?
|
| Mice, Inbred C3H | 4 | 2010 | 174 | 0.080 |
Why?
|
| Trypanosoma cruzi | 1 | 2008 | 49 | 0.080 |
Why?
|
| Protein Structure, Quaternary | 1 | 2008 | 99 | 0.080 |
Why?
|
| Lysine | 1 | 2008 | 75 | 0.080 |
Why?
|
| NADPH Oxidase 2 | 3 | 2013 | 35 | 0.080 |
Why?
|
| Cathepsin L | 2 | 2022 | 20 | 0.070 |
Why?
|
| Tyrosine | 1 | 2007 | 95 | 0.070 |
Why?
|
| Rhabdoviridae Infections | 1 | 2007 | 5 | 0.070 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2007 | 16 | 0.070 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2007 | 19 | 0.070 |
Why?
|
| Glycolipids | 1 | 2007 | 44 | 0.070 |
Why?
|
| Endoplasmic Reticulum | 2 | 2009 | 167 | 0.070 |
Why?
|
| Onchocerca volvulus | 1 | 2007 | 2 | 0.070 |
Why?
|
| HMGB1 Protein | 1 | 2007 | 25 | 0.070 |
Why?
|
| Wolbachia | 1 | 2007 | 3 | 0.070 |
Why?
|
| Brugia malayi | 1 | 2007 | 23 | 0.070 |
Why?
|
| Models, Molecular | 4 | 2014 | 1115 | 0.070 |
Why?
|
| Necrosis | 2 | 2017 | 138 | 0.070 |
Why?
|
| Amyloid beta-Peptides | 1 | 2008 | 189 | 0.070 |
Why?
|
| Blotting, Western | 3 | 2015 | 594 | 0.070 |
Why?
|
| Phosphates | 1 | 2007 | 88 | 0.070 |
Why?
|
| Adoptive Transfer | 2 | 2018 | 145 | 0.070 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2006 | 12 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 675 | 0.070 |
Why?
|
| Bone Marrow | 3 | 2016 | 173 | 0.070 |
Why?
|
| Genome, Viral | 1 | 2007 | 120 | 0.070 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2007 | 248 | 0.070 |
Why?
|
| Phospholipids | 1 | 2006 | 79 | 0.060 |
Why?
|
| Obesity | 1 | 2013 | 1189 | 0.060 |
Why?
|
| Serine | 2 | 2020 | 83 | 0.060 |
Why?
|
| Interleukin-8 | 1 | 2005 | 84 | 0.060 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2025 | 8 | 0.060 |
Why?
|
| Stilbenes | 1 | 2005 | 46 | 0.060 |
Why?
|
| Enterovirus B, Human | 1 | 2025 | 22 | 0.060 |
Why?
|
| Dengue | 1 | 2005 | 93 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 3 | 2014 | 498 | 0.060 |
Why?
|
| GATA6 Transcription Factor | 1 | 2024 | 3 | 0.060 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2024 | 6 | 0.060 |
Why?
|
| Dengue Virus | 1 | 2005 | 95 | 0.060 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2004 | 4 | 0.060 |
Why?
|
| Phosphorothioate Oligonucleotides | 1 | 2024 | 10 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2004 | 22 | 0.060 |
Why?
|
| Base Sequence | 3 | 2014 | 1308 | 0.060 |
Why?
|
| Poxviridae | 1 | 2004 | 5 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2004 | 61 | 0.060 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 307 | 0.060 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2024 | 55 | 0.060 |
Why?
|
| Protein Conformation | 1 | 2007 | 762 | 0.060 |
Why?
|
| Fas-Associated Death Domain Protein | 2 | 2015 | 11 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 1 | 2004 | 90 | 0.060 |
Why?
|
| Regeneration | 1 | 2024 | 90 | 0.060 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2004 | 33 | 0.060 |
Why?
|
| Fibrosis | 2 | 2017 | 151 | 0.060 |
Why?
|
| Cellular Senescence | 1 | 2024 | 103 | 0.060 |
Why?
|
| B7-H1 Antigen | 1 | 2024 | 53 | 0.060 |
Why?
|
| Dogs | 1 | 2025 | 313 | 0.050 |
Why?
|
| Models, Biological | 4 | 2010 | 1137 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2018 | 101 | 0.050 |
Why?
|
| Luciferases | 3 | 2013 | 109 | 0.050 |
Why?
|
| RANK Ligand | 1 | 2023 | 24 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 185 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2004 | 342 | 0.050 |
Why?
|
| Middle Aged | 4 | 2024 | 16227 | 0.050 |
Why?
|
| Adult | 4 | 2024 | 15726 | 0.050 |
Why?
|
| Immunity, Mucosal | 2 | 2014 | 46 | 0.050 |
Why?
|
| Alleles | 2 | 2015 | 425 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2004 | 194 | 0.050 |
Why?
|
| Butyrates | 1 | 2022 | 13 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 52 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2024 | 190 | 0.050 |
Why?
|
| Proteome | 1 | 2023 | 135 | 0.050 |
Why?
|
| Adolescent | 3 | 2021 | 5913 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2022 | 17 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2022 | 77 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2014 | 276 | 0.050 |
Why?
|
| United States | 1 | 2015 | 7488 | 0.050 |
Why?
|
| Radiation Chimera | 2 | 2016 | 57 | 0.050 |
Why?
|
| Time Factors | 4 | 2013 | 3564 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2022 | 104 | 0.050 |
Why?
|
| Motor Activity | 1 | 2024 | 342 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 97 | 0.050 |
Why?
|
| Xenopus | 1 | 2001 | 53 | 0.050 |
Why?
|
| Xenopus Proteins | 1 | 2001 | 34 | 0.050 |
Why?
|
| Epitopes | 1 | 2022 | 298 | 0.050 |
Why?
|
| Sex Factors | 1 | 2024 | 959 | 0.050 |
Why?
|
| src-Family Kinases | 2 | 2012 | 60 | 0.050 |
Why?
|
| Microtubule-Organizing Center | 1 | 2020 | 6 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 357 | 0.050 |
Why?
|
| Proteomics | 1 | 2022 | 252 | 0.050 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2011 | 26 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2012 | 106 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2018 | 1836 | 0.050 |
Why?
|
| Pyrin Domain | 1 | 2020 | 3 | 0.040 |
Why?
|
| Plant Diseases | 1 | 2000 | 11 | 0.040 |
Why?
|
| Surface Plasmon Resonance | 1 | 2020 | 33 | 0.040 |
Why?
|
| Synovial Fluid | 1 | 2020 | 29 | 0.040 |
Why?
|
| Glycolysis | 1 | 2020 | 54 | 0.040 |
Why?
|
| Toll-Like Receptor 8 | 2 | 2014 | 44 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1222 | 0.040 |
Why?
|
| Bacterial Load | 1 | 2020 | 29 | 0.040 |
Why?
|
| Microarray Analysis | 2 | 2013 | 57 | 0.040 |
Why?
|
| Gout | 1 | 2020 | 53 | 0.040 |
Why?
|
| Young Adult | 2 | 2021 | 4317 | 0.040 |
Why?
|
| Precipitin Tests | 3 | 2004 | 79 | 0.040 |
Why?
|
| Rats | 2 | 2013 | 1907 | 0.040 |
Why?
|
| Plant Proteins | 1 | 2000 | 83 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 129 | 0.040 |
Why?
|
| Forecasting | 1 | 2000 | 221 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 846 | 0.040 |
Why?
|
| Microtubules | 1 | 2020 | 211 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2006 | 502 | 0.040 |
Why?
|
| Transcription Factor RelB | 1 | 2018 | 5 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 483 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2020 | 553 | 0.040 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2009 | 64 | 0.040 |
Why?
|
| Ovalbumin | 1 | 2018 | 112 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2020 | 257 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 89 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2005 | 808 | 0.040 |
Why?
|
| Chromosomes | 1 | 2019 | 133 | 0.040 |
Why?
|
| Lymphadenopathy | 1 | 2017 | 23 | 0.040 |
Why?
|
| Saliva | 1 | 2018 | 96 | 0.040 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2017 | 26 | 0.040 |
Why?
|
| Proteolysis | 1 | 2018 | 137 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2004 | 617 | 0.040 |
Why?
|
| Ribonuclease III | 1 | 2017 | 81 | 0.040 |
Why?
|
| Neurons | 2 | 2013 | 856 | 0.040 |
Why?
|
| Klebsiella | 1 | 2017 | 9 | 0.040 |
Why?
|
| Aged | 2 | 2024 | 13284 | 0.040 |
Why?
|
| Ubiquitin | 2 | 2009 | 95 | 0.030 |
Why?
|
| Carbon Tetrachloride | 1 | 2016 | 9 | 0.030 |
Why?
|
| Radiation, Ionizing | 1 | 2016 | 16 | 0.030 |
Why?
|
| Whole-Body Irradiation | 1 | 2016 | 31 | 0.030 |
Why?
|
| Genome | 1 | 2019 | 252 | 0.030 |
Why?
|
| Biotransformation | 1 | 2016 | 20 | 0.030 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2016 | 4 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2016 | 121 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2016 | 56 | 0.030 |
Why?
|
| Immunoprecipitation | 2 | 2007 | 116 | 0.030 |
Why?
|
| Astrocytes | 1 | 2016 | 115 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 2016 | 77 | 0.030 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2015 | 5 | 0.030 |
Why?
|
| Splenomegaly | 1 | 2015 | 22 | 0.030 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2015 | 8 | 0.030 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2015 | 13 | 0.030 |
Why?
|
| Toll-Like Receptor 6 | 2 | 2007 | 13 | 0.030 |
Why?
|
| Brucella abortus | 1 | 2015 | 5 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 168 | 0.030 |
Why?
|
| Dynamins | 1 | 2015 | 12 | 0.030 |
Why?
|
| Antimetabolites | 1 | 2015 | 17 | 0.030 |
Why?
|
| Iron | 1 | 2016 | 144 | 0.030 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2015 | 7 | 0.030 |
Why?
|
| Drosophila melanogaster | 2 | 2012 | 480 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2015 | 50 | 0.030 |
Why?
|
| Endoribonucleases | 1 | 2015 | 52 | 0.030 |
Why?
|
| Skin | 1 | 2018 | 350 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 75 | 0.030 |
Why?
|
| Chemokine CCL4 | 1 | 2014 | 14 | 0.030 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2005 | 32 | 0.030 |
Why?
|
| RNA, Protozoan | 1 | 2014 | 9 | 0.030 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2014 | 9 | 0.030 |
Why?
|
| Intestine, Large | 1 | 2014 | 5 | 0.030 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2014 | 3 | 0.030 |
Why?
|
| Malaria Vaccines | 1 | 2014 | 24 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 350 | 0.030 |
Why?
|
| Cell Communication | 1 | 2015 | 129 | 0.030 |
Why?
|
| Vaccines | 1 | 2016 | 97 | 0.030 |
Why?
|
| Tripartite Motif Proteins | 1 | 2014 | 39 | 0.030 |
Why?
|
| Gonorrhea | 1 | 2017 | 196 | 0.030 |
Why?
|
| Infant | 2 | 2018 | 1527 | 0.030 |
Why?
|
| Epithelium | 1 | 2014 | 96 | 0.030 |
Why?
|
| Immunoglobulin epsilon-Chains | 1 | 2014 | 3 | 0.030 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 2014 | 5 | 0.030 |
Why?
|
| Phenylenediamines | 1 | 2014 | 5 | 0.030 |
Why?
|
| Allyl Compounds | 1 | 2013 | 3 | 0.030 |
Why?
|
| Polymerization | 1 | 2014 | 35 | 0.030 |
Why?
|
| Ribosomal Proteins | 1 | 2014 | 41 | 0.030 |
Why?
|
| Virulence | 1 | 2014 | 189 | 0.030 |
Why?
|
| Quinazolines | 1 | 2013 | 22 | 0.030 |
Why?
|
| Autoantigens | 1 | 2014 | 125 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2014 | 85 | 0.030 |
Why?
|
| Neuroglia | 1 | 2014 | 79 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 64 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2014 | 47 | 0.030 |
Why?
|
| Endocytosis | 1 | 2014 | 148 | 0.030 |
Why?
|
| BALB 3T3 Cells | 1 | 2013 | 5 | 0.030 |
Why?
|
| Herpes Simplex | 1 | 2014 | 46 | 0.030 |
Why?
|
| Escherichia coli Infections | 1 | 2014 | 87 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 643 | 0.030 |
Why?
|
| Terpenes | 1 | 2013 | 25 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 208 | 0.030 |
Why?
|
| Plasmids | 2 | 2004 | 280 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2013 | 46 | 0.030 |
Why?
|
| Colon | 1 | 2014 | 137 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2013 | 22 | 0.030 |
Why?
|
| Turpentine | 1 | 2013 | 2 | 0.030 |
Why?
|
| Cytidine Deaminase | 1 | 2014 | 81 | 0.030 |
Why?
|
| Interleukin-15 | 1 | 2013 | 21 | 0.030 |
Why?
|
| Protein Modification, Translational | 1 | 2012 | 5 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 2004 | 474 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 2013 | 83 | 0.030 |
Why?
|
| Onium Compounds | 1 | 2012 | 1 | 0.030 |
Why?
|
| Oxidants | 1 | 2012 | 18 | 0.030 |
Why?
|
| Prion Proteins | 1 | 2012 | 4 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2013 | 178 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2013 | 159 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2013 | 252 | 0.030 |
Why?
|
| Kidney | 2 | 2005 | 391 | 0.030 |
Why?
|
| Infection Control | 1 | 2013 | 94 | 0.030 |
Why?
|
| Shock, Septic | 1 | 2014 | 90 | 0.030 |
Why?
|
| Syndrome | 1 | 2013 | 173 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 1447 | 0.030 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2012 | 8 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2013 | 576 | 0.030 |
Why?
|
| Cryoelectron Microscopy | 1 | 2014 | 163 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2013 | 485 | 0.030 |
Why?
|
| Acetylation | 1 | 2012 | 111 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 351 | 0.030 |
Why?
|
| ral GTP-Binding Proteins | 1 | 2012 | 4 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2004 | 201 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 254 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2011 | 12 | 0.020 |
Why?
|
| Triglycerides | 1 | 2013 | 242 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 158 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2013 | 157 | 0.020 |
Why?
|
| Leukocytes | 1 | 2012 | 107 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2014 | 377 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2012 | 98 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2011 | 13 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 397 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2013 | 427 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 292 | 0.020 |
Why?
|
| Escherichia coli Proteins | 1 | 2014 | 258 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 5063 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2013 | 291 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 219 | 0.020 |
Why?
|
| Nasal Mucosa | 1 | 2011 | 16 | 0.020 |
Why?
|
| Carrier State | 1 | 2011 | 18 | 0.020 |
Why?
|
| Virus Internalization | 1 | 2012 | 95 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2011 | 52 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2013 | 262 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 303 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2011 | 43 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2012 | 527 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2011 | 110 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 338 | 0.020 |
Why?
|
| Sirolimus | 1 | 2011 | 72 | 0.020 |
Why?
|
| Nucleoproteins | 1 | 2010 | 31 | 0.020 |
Why?
|
| Drosophila | 1 | 2013 | 419 | 0.020 |
Why?
|
| Genes, Viral | 1 | 2010 | 55 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2010 | 7 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 2010 | 31 | 0.020 |
Why?
|
| Cathepsin B | 1 | 2010 | 12 | 0.020 |
Why?
|
| Transgenes | 1 | 2011 | 171 | 0.020 |
Why?
|
| Protein Folding | 1 | 2012 | 256 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2011 | 177 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 2010 | 33 | 0.020 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2010 | 7 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2010 | 39 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2010 | 43 | 0.020 |
Why?
|
| Dextran Sulfate | 1 | 2010 | 36 | 0.020 |
Why?
|
| Phagocytes | 1 | 2010 | 49 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2010 | 97 | 0.020 |
Why?
|
| Calcium | 1 | 2013 | 552 | 0.020 |
Why?
|
| Crystallization | 1 | 2010 | 97 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2010 | 187 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2010 | 132 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 2010 | 59 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2009 | 5 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2009 | 14 | 0.020 |
Why?
|
| Diet | 1 | 2014 | 635 | 0.020 |
Why?
|
| Acetylmuramyl-Alanyl-Isoglutamine | 1 | 2009 | 10 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2014 | 681 | 0.020 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2009 | 9 | 0.020 |
Why?
|
| Lipopeptides | 1 | 2009 | 17 | 0.020 |
Why?
|
| Oligoribonucleotides | 1 | 2009 | 14 | 0.020 |
Why?
|
| Hyaluronic Acid | 1 | 2010 | 63 | 0.020 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2009 | 4 | 0.020 |
Why?
|
| Pneumonia, Bacterial | 1 | 2010 | 86 | 0.020 |
Why?
|
| E-Box Elements | 1 | 2009 | 4 | 0.020 |
Why?
|
| Cathepsin K | 1 | 2009 | 7 | 0.020 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2009 | 4 | 0.020 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2009 | 6 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2009 | 41 | 0.020 |
Why?
|
| Calgranulin A | 1 | 2009 | 5 | 0.020 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2009 | 3 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2009 | 44 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2009 | 98 | 0.020 |
Why?
|
| S100 Proteins | 1 | 2009 | 21 | 0.020 |
Why?
|
| STAT6 Transcription Factor | 1 | 2008 | 7 | 0.020 |
Why?
|
| Listeria | 1 | 2008 | 11 | 0.020 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2009 | 13 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2008 | 21 | 0.020 |
Why?
|
| Aluminum Compounds | 1 | 2008 | 10 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 253 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2009 | 99 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2009 | 179 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 291 | 0.020 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2009 | 79 | 0.020 |
Why?
|
| Aorta | 1 | 2009 | 103 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2008 | 194 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 254 | 0.020 |
Why?
|
| Silicon Dioxide | 1 | 2008 | 59 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2009 | 185 | 0.020 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2007 | 17 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2009 | 228 | 0.020 |
Why?
|
| Wuchereria | 1 | 2007 | 2 | 0.020 |
Why?
|
| Rickettsiaceae Infections | 1 | 2007 | 5 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 2007 | 49 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2007 | 54 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2007 | 65 | 0.020 |
Why?
|
| Symbiosis | 1 | 2007 | 29 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 462 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 873 | 0.020 |
Why?
|
| Protozoan Infections | 1 | 2006 | 3 | 0.020 |
Why?
|
| Antiprotozoal Agents | 1 | 2006 | 8 | 0.020 |
Why?
|
| Diaminopimelic Acid | 1 | 2006 | 8 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2009 | 454 | 0.020 |
Why?
|
| Condylomata Acuminata | 1 | 2006 | 9 | 0.020 |
Why?
|
| Interleukin-2 | 2 | 1984 | 163 | 0.020 |
Why?
|
| Myristic Acid | 1 | 2006 | 9 | 0.020 |
Why?
|
| Brazil | 1 | 2006 | 85 | 0.020 |
Why?
|
| Peptidoglycan | 1 | 2006 | 54 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2005 | 11 | 0.020 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2006 | 61 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 27 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2005 | 38 | 0.020 |
Why?
|
| Skin Diseases | 1 | 2006 | 73 | 0.020 |
Why?
|
| Periplasmic Binding Proteins | 1 | 2005 | 1 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2006 | 321 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2006 | 375 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 32 | 0.020 |
Why?
|
| Electroporation | 1 | 2005 | 31 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2005 | 37 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 720 | 0.020 |
Why?
|
| Biological Assay | 1 | 2005 | 54 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2004 | 121 | 0.010 |
Why?
|
| Receptors, Antigen | 1 | 1984 | 6 | 0.010 |
Why?
|
| Escherichia coli K12 | 1 | 2004 | 19 | 0.010 |
Why?
|
| Lauric Acids | 1 | 2004 | 1 | 0.010 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2004 | 22 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 46 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2004 | 39 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2004 | 55 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 129 | 0.010 |
Why?
|
| Sequence Homology | 1 | 2003 | 19 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2009 | 2435 | 0.010 |
Why?
|
| Lymphoma | 1 | 1983 | 98 | 0.010 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2002 | 7 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 40 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 44 | 0.010 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2002 | 37 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2002 | 98 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1982 | 142 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2002 | 112 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 123 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 453 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 692 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2006 | 403 | 0.010 |
Why?
|
| Clone Cells | 2 | 1984 | 105 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 1983 | 867 | 0.000 |
Why?
|
| Rosette Formation | 1 | 1984 | 12 | 0.000 |
Why?
|
| Sheep | 1 | 1984 | 166 | 0.000 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1984 | 108 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1983 | 182 | 0.000 |
Why?
|
| Thymus Gland | 1 | 1984 | 222 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1983 | 160 | 0.000 |
Why?
|
| Kinetics | 1 | 1982 | 732 | 0.000 |
Why?
|